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Chapter 14: Developments in treatment for drug misuse offending 
 
Introduction 
 
“Occasional drug use is not the principal cause of Britain’s drug problems. The bulk of 
drug-related harm (death, illness, crime and other social problems) occurs among the 
relatively small number of people that become dependent on Class A drugs, notably 
heroin and cocaine.” (Reuter & Stevens, 2007, p.7).  
 
The drug treatment of offenders is a contentious issue steeped in political debate and clouded in 
media commentary about the rights of those who are estimated to commit up to half of the United 
Kingdom’s acquisitive crimes (HMG, 2008). The aim of this Chapter is to provide the reader with an 
overview of developments in the treatment for drug misuse offending. Initially, however, a general 
review of drugs and crime will be conducted. This will be followed by a background review of the 
development of treatment services in the United Kingdom and the second half of the chapter 
considers recent progress in treatments for drug misuse offenders. 
 
Table 1. The United Kingdom’s Legal Classification System 
 Drug Possession: Dealing 
Class A Ecstasy, LSD, heroin, 
cocaine, crack, magic 
mushrooms, amphetamines 
(if prepared for injection). 
Up to seven years in prison 
or an unlimited fine or both. 
Up to life in prison or an 
unlimited fine or both. 
Class B Amphetamines, 
Methylphenidate (Ritalin), 
Pholcodine. 
Up to five years in prison or 
an unlimited fine or both. 
Up to 14 years in prison or 
an unlimited fine or both. 
Class C Cannabis, tranquilisers, 
some painkillers, Gamma 
hydroxybutyrate (GHB), 
Ketamine. 
Up to two years in prison or 
an unlimited fine or both. 
Up to 14 years in prison or 
an unlimited fine or both. 
Source: http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/ 
 
The methods used to define and classify drugs depend upon the need to understand use and 
abuse. Hence, whilst a biopsychological approach categorises according to psychopharmacological 
effect, a legal classification categorises on the basis of perceived health and social risk. Julien 
(2005), largely classifies drugs according to their psychopharmacological effects. Hence, whilst 
alcohol, barbiturates, benzodiazepines, and second-generation anxiolytics are defined as sedative-
hypnotic drugs, cocaine, amphetamine, caffeine and nicotine are collectively referred to as 
psychostimulants. Similarly, other drugs are defined on the basis of their biological (e.g. anti-
depressants) and therapeutic (e.g. Gingko) treatment potential. A final umbrella group of drugs are 
defined according to their abuse properties (e.g. Cannabis). Alternatively, a series of UK legislative 
procedures has resulted in a legal system that classifies drugs on the basis of their risk to the 
individual and society.  Here drugs are grouped into Classes A,B, & C (see Table 1) where guideline 
penalties are suggested for possession and dealing. Alongside these are other controlled 
substances such as inhalants, alcohol and tobacco that have age, purpose and location restrictions. 
 
This classification system forms part of a long history of UK legislative acts dating back to the 1860s 
and passing through distinct phases (Reuter & Stevens, 2007). Reuter and Stevens (2007) note that 
the first attempt to regulate the access and sale of substances occurred through the Pharmacy Act 
(1868). This resulted in the restriction of the sale of poisons and dangerous substances to 
pharmacies. During this period there were very few controls on drug use, both heroin and cocaine 
were freely available without prescription and were often sold as a panacea. For example, Coca 
Cola originally contained extracts from the coca plant and was popularised as a health and energy-
providing tonic (Maisto, Galizio & Conners, 1995). The second phase, occurring from the 1920s to 
the 1960s, referred to by Reuter and Stevens (2007) as Creating a National System, saw the 
introduction of a series of acts restricting the sale and use of opium, cocaine, morphine and heroin 
to dependent users. This phase also resulted in the criminalisation of cannabis possession. The 
third phase, Increasing Control, occurred as a result of both the increase in heroin prescribing by 
General Practitioners and the introduction and widespread use of cannabis, amphetamine and LSD 
(Reuter & Stevens, 2007). This was a tightening up and formalisation of the national system with 
key legislative acts (e.g. The Misuse of Drugs Act, 1971) imposing penalties for the possession and 
sale of illicit substances. Reuter & Stevens’ final phase, Integrating Criminal Justice and Health, 
occurred from the early 1990s onwards. This resulted in both an increase in the powers available to 
the authorities (e.g. Anti-Social Behaviour Act, 2003) and the establishment of links between the 
punitive and treatment processes (e.g. The Criminal Justice Act, 1991) 
  
The United Kingdom has the highest number of dependent drug users and one of the highest rates 
of recreational drug use in Europe (Reuter & Stevens, 2007). A recent British Crime Survey (2006) 
showed that 34.9% of the 16-59 year old people sampled reported lifetime use of an illicit substance 
with 13.9% stating that they had tried a Class A drug. Self-reported use in the past year showed that 
cannabis was the most frequently used drug (8.9%), followed by cocaine (2.4%), ecstasy (1.6%), 
amphetamine (1.3%), amyl nitrate (1.2%), and hallucinogens (1.1%). When the figures are 
calculated for people aged between 16-24 self-reported use rates increase to 45.1% with 16.9% 
reporting Class A drug use. Observation of past year use shows that 21.4% reported using 
cannabis, this is followed by cocaine (5.9%), ecstasy (4.3%), amyl nitrate (3.9%), hallucinogens 
(3.4%), and amphetamines (3.3%); see Roe and Man (2006) for full details on self-reported drugs 
use in the UK. 
 
 
Defining drug misuse offending 
 
Drug misuse offending may be defined as any unlawful act associated with drug use. Hence, a 
person may be labelled a drug misuse offender if they have used an illicit drug, allowed drug use on 
their premises or have committed an offence whilst intoxicated with either an illicit drug or a legal 
controlled substance. However, the focus on misuse offending is generally directed to situations 
where the individual is either selling illicit drugs or is engaging in a drug-taking/acquisitive offending 
pattern of behaviour. The two drugs (and their derivatives) most commonly associated with these 
crime-spree scenarios are opium (heroin, morphine) and cocaine (crack); this association is linked 
to the notion that these drugs are the most likely to lead to dependence. A recent estimate suggests 
that there are 327,000 regular users of these drugs in the United Kingdom, with 281,000 opiate 
users and 193,000 crack-cocaine users (HMG, 2008). Hammersly, Marsland and Reid’s (2003) 
analysis of young offenders and drug use found that the type of offence most commonly linked to 
substance use was theft (92% of cohort). This was followed by wilful damage (80%), shoplifting 
(80%), fighting/disorder (71%), buying stolen goods (70%) and selling stolen goods (70%). The 
proposed economic cost of drug misuse offending in the UK is £15.4 billion (HMG, 2008).  A general 
estimate of the US costs of all types of substance use in 2002 was $430 billion with $170 billion of 
that cost linked to alcohol use and $138 billion linked to cigarette smoking (cited in Julien, 2005). 
  
As noted, the popularised link between drugs and offending posits the individual as an addict 
committing crimes to fund their habit; the economic necessity hypothesis. However, recent reviews 
of research into the link between drugs and crime have challenged this model (Albery, McSweeney, 
& Hough, 2003; Pudney, 2002; Seddon, 2000). For example, Pudney’s  (2002) study of the 
sequence of initiation in to crime and drugs showed that criminal and truanting activities preceded 
drug taking per se, occurring up to four years prior to the age of onset for drugs associated with the 
economic necessity model; crack cocaine and heroin. Thus, research and review materials tend to 
proffer a complex interaction between drug taking and other criminal activities that also requires the 
consideration of tobacco, alcohol, family circumstances, deprivation and schooling. Albery et al. 
(2003) cite five potential links between drugs and crime. These are: 
 
1. The act of taking drugs is a criminal act 
2. Drug taking may lead to other forms of crime 
3. Non-drug taking crimes may lead to drug taking 
4. There is a complex interaction between drug taking and other crimes 
5. There are associated causes that lead to both non-drug taking and drug taking crimes 
 
The link is further compounded through the inevitability of a drug causes crime scenario, suggesting 
the likelihood of an eventual causal relationship arising from drug dependence (Bennett & Holloway, 
2005). Further, the statistics also indicate that young males are most likely to commit crimes (14-18 
years old) at the same age that they are also likely to try drugs. Finally, statistics on the numbers of 
prisoners who have drug misuse problems further obscure the association. For example, Penfold, 
Turnbull and Webster’s (2005) study of current prisoners and prison staff in six prisons in the UK 
suggested that heroin, crack cocaine, and cannabis use were prevalent.  
 
However we choose to understand the association between drug misuse and criminal behaviour, 
interventions and treatments are justified on the basis that: there is clear evidence that drug 
misusers are likely engage in crime-spree behaviour; drug misuse increases the likelihood of 
offending; and, as a group, drug misusers have higher levels of contact with the criminal justice 
system (McSweeney, Turnbull & Hough, 2008).  
 
The Development of Intervention and Treatment Programmes 
 
“Treatment can be defined in general terms as the provision of one or more structured 
interventions designed to manage health and other problems as a consequence of 
drug abuse and to improve or maximize personal social functioning.” (UNDOC, 2003, 
Chapter II, p.2) 
 
An observation of the history of interventions and treatments for drug misuse shows cycles of 
tolerance and prohibition (Blume, 2000).  The earliest forms of intervention occurred as a response 
to opium dependence and were largely administered by General Practitioners (GPs). A well known 
example is the British Model, whereby until the 1960s GPs were free to prescribe heroin and 
cocaine to those they diagnosed as dependent. The patients then picked up the drugs from their 
pharmacy. As this practice resulted in a minority of GPs over-prescribing the procedure was 
stopped in 1967 (The Dangerous Drugs Act) and 1,000s of people were referred to newly 
established specialist Drug Dependency Units (Farrell, Sheridan, Griffiths & Strang, 1998). 
 
In the 1960s an increase in illicit drug use occurred as the drug culture in the USA became popular 
in the UK. Consequently, many of the early treatments and interventions were based upon those 
that had been developed in the USA. The earliest examples of these were, Christian-based 
programmes and therapeutic communities. The most accessible and easily transferable model was 
the twelve-step programme (or Minnesota Method) that had been adapted from alcoholics 
anonymous (AA) to narcotics anonymous (NA). These programmes adopted a disease-based 
model of alcohol and drug dependence with a spiritual method of sustained recovery. The first 
seven steps (see Figure 1.) focus upon an acknowledgement of the addiction and a desire to 
withdraw from drug taking. The final five steps resolve to maintain the change in behaviour and 
rectify the problems they have caused. These steps are the focus of anonymous meeting groups.  
Therapeutic communities also emerged during this period. The aim of this approach was to provide 
an asylum for drug users where peers are encouraged to both support each-other in abstinence and 
confront each-other in doubt. Two similar approaches emerged, first the user-oriented and 
democratic UK based Maxwell Jones model such as the Phoenix House Project and second the 
USA based Synanon approach such as the Richmond Fellowship Crescent House Project (Dale-
Perera, 1998). Finally, this period also witnessed the development of non-statutory street-based 
agencies offering informal advice, counselling and information to drug users (Dale-Perera, 1998). 
 
Figure 1. The 12 Steps (Alcoholics Anonymous, 2001) 
1. We admitted we were powerless over alcohol—that our lives had become unmanageable. 
2. Came to believe that a Power greater than ourselves could restore us to sanity. 
3. Made a decision to turn our will and our lives over to the care of God as we understood Him. 
4. Made a searching and fearless moral inventory of ourselves. 
5. Admitted to God, to ourselves, and to another human being the exact nature of our wrongs. 
6. Were entirely ready to have God remove all these defects of character. 
7. Humbly asked Him to remove our shortcomings. 
8. Made a list of all persons we had harmed, and became willing to make amends to them all. 
9. Made direct amends to such people wherever possible, except when to do so would injure 
them or others. 
10. Continued to take personal inventory and when we were wrong promptly admitted it. 
11. Sought through prayer and meditation to improve our conscious contact with God as we 
understood Him, praying only for knowledge of His Will for us and the power to carry that 
out. 
12. Having had a spiritual awakening as the result of these steps, we tried to carry this message 
to alcoholics, and to practice these principles in all our affairs. 
 
 
The 1970s and 1980s saw further developments in the treatment of drug users. The Misuse of 
Drugs Act (1971) established clear penalties for drug users and dealers. Drug workers and Drug 
teams were established, those who worked with drug users came together to form integrated units 
and SCODA (Standing Conference on Drug Abuse) was established to bring together non-statutory 
services (Dale-Perera, 1998). There was also an increase in substitute opiate prescribing for heroin 
users with a tendency to prescribe oral rather than injecting methadone (Farrell et al., 1998). The 
most important factor occurring during this period was the emergence of HIV/AIDS in the mid to late 
1980s. This threatened to reach epidemic proportions in those who injected drugs and led to a rise 
in harm reduction procedures.  As the threat of HIV/AIDS became bigger than the danger of drug 
using, outreach projects developed that focused upon helping hard-to-reach users. Similarly, 
needle-exchange schemes were set up that supplied clean injecting equipment and safe disposal 
units (Dale-Perera, 1998). Finally, the use of drug rooms was piloted in the Netherlands. The 
policies, interventions and treatments in the 1980s were characterized by a general rhetoric 
supporting hard-line abstinence policies (e.g. the Raegan’s “Just Say No!” campaign) set against 
local-level implementations of harm reduction procedures designed to avoid the spreading of 
infectious diseases.  
 
The early 1990s showed a dramatic change in drug policy, harm prevention and reduction merged 
into an integrated whole and there was a specific emphasis upon developing a consistent policy 
with measurable outcomes such as the Home Office’s Drug Harm Index (DHI). The Criminal Justice 
Act (1991) refocused the debate with the formal introduction of treatment as a condition of 
probation. This was followed by the Government’s Tackling Drugs Together proposal that required 
the police to introduce drug strategies, and later by the Crime and Disorder Act (1998) which 
required Drug Treatment and Testing Orders (DTTO). Coupled with these initiatives was the short-
lived introduction of a UK Drug Czar (Keith Haliwell), the development of a National Treatment 
Agency and National and local information (FRANK) and communication (Connections) 
programmes. These more recent developments emphasise abstinence, treatment and harm 
reduction in a unified package of services aimed at reducing drug misuse offending. 
 
From the ad hoc developments in the 1960s interventions and treatments have proliferated, targets 
have been set and achieved on the number of people receiving help (HMG, 2008), points of access 
have been varied to include the hard-to-reach clients and there is a transition from service to 
service. Prior to providing an overview of the UK’s present system of services a brief review of the 
types of treatment available will be given. Stevens, Hallam, and Trace (2006) provide a thorough 
overview of the different types of treatment available to problem drug users. These include: low 
threshold; detoxification; pharmacotherapies; talking therapies; and alternative therapies. The 
following summary will adopt this classification. 
 Low threshold services are those that provide simple and efficient ways of reducing problem drug 
use threats. They include, drop-in services, needle exchange, targeted delivery of health care, 
outreach services, and drug consumption rooms (Stevens et al., 2006). Drop-in services provide 
basic lifeline assistance such as food, clothing and shelter, as well as advice on employment, health 
and welfare.   These services may act as vital communication points that maintain the contact 
between the problem drug user and the services provided to assist them back into society. As 
noted, needle exchange services arose from the fears of HIV/AIDS and more recently Hepatitus B 
and C. They provide users with the paraphernalia required to avoid these infectious diseases; 
needles, syringes, spoons, filters, water, citric acid, and condoms. Initial fears that these services 
would increase drug use proved to be unfounded and considerable research has shown that they 
play an important role in reducing blood-borne diseases in drug users; see Gibson, Flynn, and 
Peralec’s (2001) meta-review of research.  
 
To provide a targeted healthcare delivery service it is necessary to set up clinics close to areas of 
high drug use. They may provide professional or peer assistance, shelter, or medical services to 
hard-to-reach groups such as, the homeless, sex workers and other vulnerable groups (Stevens et 
al., 2006). The most controversial low threshold service is the drug consumption room. Like most of 
these interventions the rooms emerged in the late 1980s from the need to protect injecting users 
from infectious diseases. Reviews of the use of safe rooms show that they provide a range of 
services that reduce needle sharing and assist in the welfare and education of high risk users (Kerr, 
Tyndall, Li, Montaner & Wood, 2005; and, Kimber, Dolan & Wodak, 2005).   
 
“Multiperson use of needles and syringes contributes to a considerable illness burden in 
both developed and developing countries. Use of nonsterile syringes can occur within 
the context of illicit drug injection and is associated with transmission of blood-borne 
pathogens, including HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV), human 
Tcell lymphotropic viruses, and even malaria. Syringe sharing, or even reuse of syringes 
by the same person, increases the risk of endocarditis, cellulitis, and abscesses.” 
(Strathdee & Vlahov, 2001, p.1). 
 
The second category of treatments listed by Stevens et al. (2006) are detoxification procedures. 
The aim of a detoxification programme is to decrease the drug users physical and psychological 
dependence on a drug. This is a difficult procedure as detoxification leads to a host of withdrawal 
symptoms (e.g. pain, fever, and craving). Consequently, users are often placed on substitute drugs 
that are less harmful but mimic some of the effects of the drug (e.g. methadone as a replacement 
for heroin) or they are given drugs that block the effects of the to-be-withdrawn substance (e.g. 
naltrexone decreases the effect of heroin). These procedures are carefully introduced and 
monitored (the maintenance programme) and are coupled with psychological and social 
counselling. A successful programme removes dependence whilst limiting the amount of trauma to 
the individual.  In the past two decades ultra-rapid opioid detoxification (UROD) programmes have 
been developed which combine the antagonist effects of naloxone and naltrexone with the 
analgesic and sedative effects of anaesthetics. The purpose of these 4-6 hour detoxification 
procedures is to remove the intolerable effects of dependence as quickly as possible (see Kaye, 
Gevirtz, Bosscher, Duke, Frost, Richards, & Fields, 2003). UROD is not a magic bullet, and the 
effects of withdrawal persist but the aim is set them at manageable levels so they can be dealt with 
on a symptom-to-symptom basis.  
 
In order for detoxification to succeed the drug user must be highly motivated to come off the drug. 
Unfortunately the level of commitment is too strong for every dependent user to succeed and in 
these circumstances an alternative pharmacotherapeutic may be adopted. This involves the 
prescribed replacement of the harmful drug with a less dangerous alternative. Following the 
withdrawal of L-alpha acetylmethadol (LAAM) in 2004 the main drugs used to substitute opiate 
dependence are Methadone and Buprenorphine. Controversially, dexamphetamine may be used to 
treat cocaine dependence, however, due to potentially dangerous side-effects this should be done 
in conjunction with continued medical examination (Stevens et al., 2006). The importance of 
pharmacotherapies to both the individual and society is highlighted by Julien’s review of the 
treatment of opiate dependence: 
 
“Opioid dependence is a brain-related medical disorder (characterized by predictable 
signs and symptoms) that can be effectively treated with significant benefits for the 
patient and for society. However, society must make a commitment to offer effective 
treatment for opioid dependence to all who need it. Everyone dependent on opioids 
should have access to methadone, LAAM, or buprenorphine maintenance therapy in a 
methadone clinic or in a physician’s office.” (2005, p. 494). 
  
Reviews of the use of substitute drugs to treat drug misuse offenders have shown that they are 
affective in reducing both drug misuse and acquisitive offending (Hammersley, Forsyth, Morrison & 
Davies, 1989).  
 
The fourth category of treatments listed by Stevens et al. (2006) are talking therapies. Therapeutic 
communities (TC) have been an integral feature of drug treatment and intervention for the past 40 
years. Many of these drug-free projects that thrived into the 1980s have since faced hard social and 
economic challenges. The emergence of the HIV/AIDS epidemic reframed the treatment process 
toward a harm reduction approach that sat awkwardly beside the abstinence ideology of the TC 
(Broekaert, 2006). Residential rehabilitation is particularly problematic because it is both an 
expensive and selective form of treatment.  Projects are trapped in an economic-quality cycle with a 
value system excluding the hard-to-reach drug misuse offenders and an environment that has 
difficulty tackling the psycho-social aspects of dependence. These projects were developed through 
the belief that substance dependent individuals are capable of removing drugs from their lives. In 
the first decade of the 21st Century they are adapting to social and economic needs.  As Broekaert 
states in his review of the future of the TC in Europe: 
 
“The drug-free TC extended its approach to other target groups, such as prisoners, 
mothers and children, adolescents, dually diagnosed residents, methadone maintained 
clients, chronic abusers and mental health patients. TC treatment, methadone 
programmes and harm reduction methods have been integrated. Brief interventions have 
been introduced that utilize family and social network support. The TC movement has 
adopted post-modern approaches that advocate the introduction of shorter programmes, 
de-institutionalization, outreach and community-based interventions.” (2006, p. 1678) 
 
 
Many of the contemporary talking therapies are based upon an eclectic mixture of humanistic, 
behavioural and cognitive approaches. Stevens et al. (2006) highlight three types of therapy 
(motivational interviewing, cognitive behavioural approaches and community reinforcement and 
contingency contracting) that have all been successfully applied to substance dependent 
individuals. Motivational interviewing is a non-coercive, goal-directed, client-centred counselling 
technique aimed at identifying and focusing upon ambivalence. It is normally applied to addictive 
behaviours but may be used in other circumstances (Rollnick & Miller, 1995). The key to 
motivational interviewing is to encourage the client to recognise that there is conflict in their lives. It 
neither aims to diagnose the source of the conflict nor to offer specific advice on how to change the 
behaviours. In this respect it differs from traditional methods that seek change through 
confrontation. 
 
Motivational interviewing may be used as an early assessment approach in a structured prevention 
programme that includes cognitive behavioural therapy (CBT) and community reinforcement and 
contingency contracting. CBT is a general approach premised by the notion that thoughts, 
behaviours and emotions are fundamentally entwined in the individual. CBT works in the present to 
change problematic thoughts and behaviours. Its aim is to provide drug misuse offenders with the 
skills and strategies to avoid offending behaviours. The effectiveness of CBT is dependent upon the 
implementation services that assist the opportunity for change. These reinforcements and 
contingencies include, family counselling, providing drug-free social networks, improving job 
opportunities, and implementing positive reward programmes such as token economies (Stevens et 
al., 2006).  
 
Example DIP Success Story: Brian (pseudonym) Male, 37 
Intervention: CARAT services in prison; Probation supervision and community treatment; Police 
monitoring via PPO scheme 
Case and Outcome: Brian had a total of 46 previous convictions spanning a 20-year period and was 
responsible for 125 criminal offences including burglary, theft, fraud, assault, drugs and firearms 
offences. He served several prison sentences and his last saw him released in July 2007. He had 
PPO [Prolific and other Priority Offender] status for several years and had caused the local 
community much harm and distress. Brian had a long history of Class A drugs misuse and had a 
heroin and crack cocaine addiction for several years. He first tested positive on arrest in July 2004. 
DIP measures have been taken since this and the police team have continually enforced treatment 
conditions when in force and offered treatment through DIP treatment providers at other times. As a 
result, Brian has not been arrested since July 2007 and has been in drug treatment since his last 
release from prison. He is prescribed methadone through local drug services and has engaged in 
the 12-step programme. Brian has not taken illegal drugs in all that time. He is now being removed 
from the PPO list and his whole attitude to life is being changed. His health is much improved and 
he has recently completed a sponsored run in aid of charity. 
Source: http://drugs.homeoffice.gov.uk/publication-search/dip/dip-success-stories-2008 
 
It is hoped that this section of the chapter has provided the reader with an overview of the context in 
which substance users offend and the general psychological methods used to enable these 
individuals to function in society. The remaining section provides an overview of how the UK has 
integrated treatments and interventions into a single and effective service. 
 
 
The UK Government’s response to drug misusing offenders  
 
“Despite some methodological limitations, recent studies seeking to assess the impact of 
the Drug Interventions Programme (DIP) have reported some successes in terms of 
delivering improved rates of engagement with drug treatment and sustaining high rates of 
retention.” (McSweeney, et al., 2008, p.6). 
 
The Drug Interventions Programme (DIP) began in April 2003 as a UK Government (Home Office) 
initiative to tackle Class A drug misuse and the associated acquisitive crime. During the early 
development of DIP there was little evidence, either in the UK or the rest of the world, from which to 
draw a macro level national programme of support and help for drug misuse offenders. 
Consequently, an indirect evidence-base and policy context was drawn from the following 
documents: Social Exclusion Unit Reducing Re-offending Report (Fox, 2002), Through The Prison 
Gates (Morgan & Owers, 2001), Justice For All White Paper (2002) and the Updated Drug Strategy 
(Home Office, 2002). From these documents, nine areas were identified as key to reducing re-
offending and drug taking behaviour. These were: education and training; employment; drugs and 
alcohol rehabilitation; mental and physical health; attitudes/life skills; housing; debt and benefits; 
and, family networks.  
 
The aim of the of the DIP was to develop throughcare and aftercare procedures that ensured a 
continuity of treatment and intervention from the drug misusers’, point of arrest, to sentencing, 
release from prison or community service, and integration back into the community. These 
procedures focus upon enabling, encouraging and coercing the individual to adopt and cope with a 
drug-free lifestyle. In order to achieve this the procedures are managed by Criminal Justice 
Integrated Teams (CJITs) outside of prisons and Counselling, Assessment, Referral, Advice and 
Throughcare (CARAT) workers inside prisons. 
 
Appropriate individuals are referred (predominantly by Criminal Justice System ‘agencies’) to CJITs 
who firstly assess the individual’s needs; see example success stories. CJIT workers then help the 
individual to access the appropriate range of interventions from the previously noted nine areas. 
CJITs use a multi-agency approach to work closely with those involved in providing the 
interventions. For example, they may seek support from, jobcentre plus, education services, GPs, 
local mental health teams, drug treatment services and housing services.  
 
Example DIP Success Story: Danielle (pseudonym) Female, 27 
Intervention: Restriction on Bail; Debt and benefit management; Housing support; Tier 3 prescribing; 
Alcohol intervention; One-to-one Sessions; Crisis intervention; Motivational interviewing; Solution 
focus therapy; Education, training and employment support. 
Case and Outcome: Danielle had been using heroin, crack and alcohol daily for seven years. During 
that time, there were only two days when she had not used. When she signed up to Kirklees DIP in 
September 2007, following her arrest, she was testing positive for opiates and cocaine. Danielle 
was also injecting in her neck and drinking heavily. She attended her Follow Up Assessment and 
met her case manager, with whom she discussed her needs and the support she required. 
Leading up to her court appearance in November 2007, Danielle was engaging with her case 
worker and regularly attending her appointments. In court she was bailed on condition she engaged 
with DIP. At that time Danielle owed £7000 in housing benefits and was also in arrears with her gas, 
water, electric and TV licence but despite these problems she completed her bail without any 
breaches and made the decision to continue to engage with DIP voluntarily. Her case worker 
referred Danielle to the DIP housing manager, who managed to get her housing arrears cancelled. 
Her case worker then dealt with all Danielle’s other outstanding bills, getting them ‘quashed’ and 
organised for her to start afresh, paying her bills weekly. 
To help with Danielle’s drinking problem she completed a “drink diary”, which involves logging 
everything you drink daily and then the following week, aiming to reduce on the previous week’s 
intake. 
When Danielle told her case worker that she was interested in getting back into computers, she was 
put in touch with Dewsbury College and attended an open day at the college, where she is now 
undertaking a computer course. Just three months after her arrest, Danielle was testing negative 
and continues to do so. She attributes her success to DIP and, of course, her case worker. 
Source: http://drugs.homeoffice.gov.uk/publication-search/dip/dip-success-stories-2008 
 
The Drug Interventions Programme also consists of a range of coercive interventions including, 
drug testing on arrest and charge, required assessment, conditional cautioning, drug rehabilitation 
requirements and required assessment. Some of these are available across England and Wales 
and some are only available in specific areas.  The idea is that the different elements of DIP 
together provide an opportunity to offer a drug misusing offender treatment and support at every 
stage of the criminal justice process. The aim is to draw as many problematic drug misusing 
offenders as possible, including those on the fringes of offending into treatment and support and to 
maximise their engagement and retention in that support.  
 
Example DIP Success Story: Martin (pseudonym) Male, 35 
Intervention: Throughcare and aftercare support, prison referral 
Case and Outcome: Martin was a prolific offender and had served 15 to 20 prison sentences. He 
had used illicit drugs since the age of 12. Coming to the end of a prison sentence for burglary, he 
was assessed and referred to relevant treatment agencies Since completing the 12-step 
programme, Martin has been in recovery for two years, hasn’t re-offended and has gained access 
through the courts to see his daughter 
Source: http://drugs.homeoffice.gov.uk/publication-search/dip/dip-success-stories-2008 
 
DIP also has strong connections with Counselling, assessment, referral, advice and throughcare 
(CARAT) workers in prisons which provide the link for drug misusing offenders from prison to 
community based support to further help maximise retention in treatment.  Some of the DIP 
measures offer offenders the choice to take up drug treatment and support in order to avoid a more 
severe criminal justice penalty. Whilst this may be viewed as a coercive form of drug treatment 
there is research to support its efficacy (Skodbo, Brown, Deacon, Cooper, Hall, Millar, Smith & 
Witham, 2007).  
Evidence suggests that DIP is having an impact on reducing drug misuse and the associated crime. 
Since DIP began drug-related crime has reduced by a fifth, furthermore over 1,000 drug misusing 
offenders have entered treatment, a ‘record number’. (www.drugs..gov.uk, 2008). Research that 
examined the DIP’s impact found that drug misusing offenders reduced their offending by 26% after 
they had been identified and maintained contact with the DIP. Nearly half of the cohort had 
reductions in offending of 79%, whilst 25% maintained a similar level of offending and 28% showed 
increased levels of offending (Skodbo, et al., 2007). However, establishing a direct cause and effect 
was not possible as no control group was used. Further research which evaluated the Aftercare 
element of DIP showed that a sample of participants on six CJIT caseloads significantly reduced 
their Class A drug misuse. Furthermore, acquisitive offending reduced by 34% for those who had 
been on the caseload of for between 11-13 weeks (Love 2007).  
Conclusion 
The aim of this Chapter is to inform the reader of a range of issues related to treatments and 
interventions for drug misuse offenders. The increase in drug use in past 50 years has caused 
considerable disruption to UK society, ruining lives, families and communities. Whilst initial ad hoc 
reactions from legislators had little impact upon the problems, recent coherent and inclusive policies 
have shown some successes. It is essential that these policies continue to be informed by 
researchers in the social sciences. It is also important that the appropriate drug treatment services 
are available to tackle those substances being abused and causing the most harm to individuals, 
communities, victims and the families of those affected.  
Further exploration of the prevalence of dual diagnosis among offending populations is necessary. 
The relationship between different types of drug misuse including poly-drug misuse and different 
types of mental ill health among both community and prison based offenders is required.  The 
efficacy of addressing mental health and dual diagnosis issues in drug treatment programmes also 
warrants attention.  
Whilst outside the scope of this chapter it is equally important to ensure that preventative measures 
are targeted at the next generation of potential problematic drug misusing offenders. This includes 
the children of drug misusing parents and the younger siblings of drug misusing offenders, which 
forward thinking programmes already address. 
  
 
Dual diagnosis & drug misusing offenders  
There is no direct evidence of a link between dual diagnosis and drug misuse offending but there is 
considerable indirect support for the importance of future investigation. Research has focused upon 
three key associations: drug misuse and mental health; prisons and mental health; and offending 
and dual diagnosis. These are discussed below. 
 
Findings in the UK indicate that mental health disorders for those with drug misuse problems are 
higher than for the general population. (Department of Health 2002). For example, Strathdee et al 
(2002) found that 93% of clients in drug misuse services indicated mild to moderate mental health 
problems; depression (41%), generalised anxiety and panic attacks (55%). Weaver et al (2002) 
found that nearly 75% of clients of drug services had mental health problems; depression and/or 
anxiety disorder (68%), severe anxiety (19%), mild (40.3%) and severe (26.9%) depression. Finally, 
Marsden et al (2000) found that 29% of opiate dependant clients in drug treatment services had 
anxiety and 26% had depression.  
 
The Social Exclusion Unit Reducing Re-offending Report (2002) found that male (x14) and female 
(x35) prisoners were more likely to have a mental health disorder than the general population. They 
found that approximately 70% prisoners had two or more mental health disorders and that 40% of 
male prisoners and 63% of female prisoners had a neurotic disorder. The Institute of Psychiatry 
(1998) found that 66% of prisoners on remand had a mental health disorder and 39% of sentenced 
prisoners had mental health disorders. The Mental Health Foundation (1998) found that 55% of 
prisoners had some form of neurotic disorder and that most prisoners had a high prevalence of 
depression and general worry. Strathdee et al (2002) study of primary care services found that 
those with an indication of dual diagnosis were at greater risk of criminal behaviour than those with 
no dual diagnosis. For example, 62% of patients in forensic services had a dual diagnosis. 
Research also shows that those with dual diagnosis were at greater risk of offending behaviour 
(Banerjee et al., 2002; Tessler & Dennis, 1989).  
 
Combined this research shows the importance of understanding the link between drug misuse, 
mental health, and offending. Especially as those with a dual diagnosis have problems accessing 
help for either their drug or mental health problem or both (Department of Health 2002, Mind 2007, 
Social Exclusion Unit 2002, Banerjee et al 2002). The Department of Health (2002) suggests this is 
because mental health and drug treatment services have developed separately and consequently 
there are few services that deal with both problems concurrently. Wanigaratne et al (2005) suggest 
that addressing a drug misuser’s mental health can have beneficial effects on their drug taking 
behaviour.  They also claim that the psychological health of clients on any drug treatment 
programme should be a key outcome measure of the efficacy of that programme (see also, Wilke, 
2004; and, Bean & Nemitz, 2004).  
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